Gabriella Scarlatti

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression

Gabriella Scarlatti, Eleonora Tresoldi, Åsa Björndal et al. · Nature Medicine · 1997 · 634 citations

Life Sciences, Immunology, Molecular Biology +15

Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype

Åsa Björndal, Hongkui Deng, Marianne Jansson et al. · Journal of Virology · 1997 · 608 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Stefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo et al. · Nature Communications · 2021 · 379 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +10

Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers.

Gabriella Scarlatti, Thomas Leitner, Eva Halapi et al. · Proceedings of the National Academy of Sciences · 1993 · 179 citations

Life Sciences, Genetics, Molecular Biology +15

Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1: Correlation with Neutralizing Antibodies against Primary Isolates

Gabriella Scarlatti, Jan Albert, Paolo Rossi et al. · The Journal of Infectious Diseases · 1993 · 178 citations

Life Sciences, Immunology, Infectious Diseases +14